Aurinia Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025

Published: 2025-05-12 06:03:00 ET AUPH

Published on 05/12/2025 at 06:03, updated on 05/12/2025 at 07:35

Aurinia Pharmaceuticals Inc. reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported revenue was USD 62.47 million compared to USD 50.3 million a year ago. Net income was USD 23.34 million compared to net loss of USD 10.75 million a year ago.

Basic earnings per share from continuing operations was USD 0.17 compared to basic loss per share from continuing operations of USD 0.07 a year ago. Diluted earnings per share from continuing operations was USD 0.16 compared to diluted loss per share from continuing operations of USD 0.07 a year ago.